ArticleJournal of inherited metabolic disease2020

Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long-term clinical outcome of classic infantile Pompe patients.

Esther Poelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.